Oxford BioTherapeutics Overview

  • Founded
  • 2003
Founded
  • Status
  • Private
  • Employees
  • 25
Employees
  • Latest Deal Type
  • PE Growth
  • Financing Rounds
  • 12

Oxford BioTherapeutics General Information

Description

Operator of a biotechnology drug discovery firm intended to develop innovative antibody therapies to treat cancer. The company has a pipeline of immune-oncology (IO) therapies that create and develop novel targeted oncology therapeutics with a focus on antibody-drug conjugates (ADC) and immune-oncology treatments.

Contact Information

Formerly Known As
Oxford Genome Sciences (UK)
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Drug Discovery
Primary Office
  • 94A Innovation Drive
  • Milton Park
  • Abingdon OX14 4RZ
  • England, United Kingdom
+44 01235 000000

Oxford BioTherapeutics Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Oxford BioTherapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Oxford BioTherapeutics‘s full profile, request access.

Request a free trial

Oxford BioTherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a biotechnology drug discovery firm intended to develop innovative antibody therapies to treat cancer. The c
Biotechnology
Abingdon, United Kingdom
25 As of 2021
000.00
0000000 0000 000.00

00000000

e dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur s
0000000000000
Waltham, MA
00 As of 0000
00000
00000000 00000

00000000

m, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irur
0000000000000
San Carlos, CA
0 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Oxford BioTherapeutics Competitors (64)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Immunogen Formerly VC-backed Waltham, MA 00 00000 00000000 00000
000000000 00000000 Venture Capital-Backed San Carlos, CA 0 000.00 0000000000 0 000.00
000 000000000 Formerly VC-backed Cambridge, MA 00 00000 00000000 00000
00000000 Venture Capital-Backed San Carlos, CA 00 00000 00000000000 00000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
You’re viewing 5 of 64 competitors. Get the full list »

Oxford BioTherapeutics Executive Team (12)

Name Title Board Seat Contact Info
Christian Rohlff Ph.D Founder, Chief Executive Officer & Board Member
Scott Sandler Vice President of Finance
Abderrahim Fandi MD Chief Medical Officer
You’re viewing 3 of 12 executive team members. Get the full list »

Oxford BioTherapeutics Board Members (12)

Name Representing Role Since
00000 000000000 00.0 Self Chairman 000 0000
000000000 000000 00.0 Oxford BioTherapeutics Founder, Chief Executive Officer & Board Member 000 0000
00000 00000 Self Board Member 000 0000
0000-000000 0000000 00 Self Board Member 000 0000
0000 00000000000 00 Self Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Oxford BioTherapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oxford BioTherapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Oxford BioTherapeutics‘s full profile, request access.

Request a free trial